SCHEMBL903792

SCHEMBL903792

BrC(Br)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.62
KMT2A Q03164 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
SGMS2 Q8NHU3 1/20 0.56
BCHE P06276 2/20 0.54
CYP4F2 P78329 1/20 0.54
CYP4A11 Q02928 1/20 0.54
MAOA P21397 1/20 0.53
NR4A2 P43354 1/20 0.53
ALOX5 P09917 2/20 0.51
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
PKM P14618 1/20 0.50
RAB9A P51151 1/20 0.50
BLM P54132 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27733470 0.87 MAOB (0.58) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL4162550 0.87 SMN1; SMN2 (0.59) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL903779 0.86 KMT2A (0.54) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL19065075 0.84 MAOB (0.55) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL16432400 0.83 MAOB (0.57) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL684282 0.83 MAOB (0.62) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL5772666 0.83 SMN1; SMN2 (0.67) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL19415790 0.83 SMN1; SMN2 (0.67) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL5772077 0.83 KMT2A (0.62) MAOBKMT2ASMN1; SMN2SGMS2BCHE
SCHEMBL29216490 0.83 KMT2A (0.58) MAOBKMT2ASMN1; SMN2SGMS2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041014-A1 TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed